1 / 18

Procurement and Supply Management Policies

Procurement and Supply Management Policies. WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies, October 2012 Sophie Logez PSM Hub. Global Fund Grants. Objective of the Global Fund “making a “sustainable and significant” contribution

suchin
Download Presentation

Procurement and Supply Management Policies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Procurement and Supply Management Policies WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies, October 2012 Sophie Logez PSM Hub

  2. Global Fund Grants Objective of the Global Fund “making a “sustainable and significant” contribution to the achievement of the Millennium Development Goals”

  3. Global Fund Top 3 result indicators (2010)

  4. Global Fund Approved Proposals By Disease Component (End 2011) Source: Global Fund Grant Data

  5. Global Fund Approved Proposals By Region (2002 to mid-2011) Source: Global Fund Grant Data

  6. Distribution of funding 37% of funds for health products

  7. Outline • Global Fund principles on PSM • QA Policy for pharmaceutical products • Price & Quality Reporting

  8. Policies and Principles for PSM • Quality-assured products • Lowest possible price • National laws and international agreements • Transparent, fair and competitive procurement • Principles and minimum standards “Operational principles for Good Pharmaceutical Procurement” • Build upon existing systems • PSM activities Outlines what PRs need to comply with

  9. QA Policy for Pharmaceutical Products (as of 2009) • Quality Criteria • For all products • Authorization for use in the recipient countries • For ARVs, anti-TB and anti-malarial products • WHO Prequalified or authorized by a Stringent Regulatory Authority; • or • Recommended for use by an Expert Review Panel, • OnlyIf <2 WHO PQed or SRA authorized products available • Monitoring Quality • Monitoring quality of products all along the supply chain • Systematic random quality control testing • Recipients report testing results to Global Fund • Clinical Criteria • Medicines listed in WHO or national or institutional Standard Treatment Guidelines • Require applicants/ recipients to provide justification for selection of unlisted products in one of the STGs + +

  10. 2. Quality Criteria 3. Monitoring Quality 1. Clinical Criteria Monitoring product quality “The quality of FPPs procured with Global Fund grant funds must be monitored.” “PRs to conduct systematic random testing, and report testing results to Global Fund” Principles of quality monitoring: • Concerns all products (including WHO-prequalified and SRA-authorized products) • Monitoring done all along the supply chain • Systematic random quality control testing (following a plan - notallproducts / lotswill be tested)

  11. 3. Monitoring Quality at country level 2. Quality Criteria 1. Clinical Criteria “Guidance for Reinforcing and /or Establishing Pharmaceutical Quality Control Systems and Related Stock Management Activities in Countries Supported by the Global Fund “ • : • support implementation of the Global Fund’s QA Policy. • provide technical guidance to recipients on quality control testing activities • http://www.theglobalfund.org/documents/psm/PSM_QCMonitoringGFPRsVP_Guide_en.pdf • Frequently Asked Questions

  12. 2. Quality Criteria 3. Monitoring Quality 1. Clinical Criteria Qualitymonitoring at country level

  13. Publication of QC Results

  14. Partnerships in Quality Assurance • Close collaboration with WHO PQ • Expert advice • QA Policy implementation: ERP management • WHO Disease Programs: HIV, Malaria, TB • Collaboration/information sharing with other donors and suppliers, such as UNICEF, UNDP • Working toward policy harmonization with partners eg. GDF • Regular communication with manufacturers: annual meeting • Monitoring QA activities and publication of results

  15. Make publicly available price and quality information • Transparency • Informed procurement decisions • Basis to develop demand forecasts • Monitor price and quality information • Price analysis report • Price trend, regional comparison • Purchase price report • QA Compliance • Analyze procurement information for policy purposes • Health Products reported: • ARVs • Antimalarial medicines • Tuberculosis medicines • Bednets • Condoms • Rapid Diagnostics Kits

  16. Global Fund Financed Procurement of key products since 2009 • From 2009-2011, more than US$ 2.122 billion1 of antiretrovirals, long-lasting insecticidal nets, antimalarial medicines and anti-TB medicines were delivered to Global Fund Principal Recipients and reported to the PQR. 1 As reported to the PQR on 02 April 2012

  17. Use of PQR in Grant Lifecycle • Budgeting & Grant negotiation • Proposal development, TRP Review, PSM Plan Review • Grant Implementation • Monitoring of compliance with QA Policy • Review by PRs of prices achieved versus peers • Grant Performance Reviews • Benchmarking of prices achieved versus peers • Review of QA issues • Identification of value for money opportunities • Transparency

More Related